| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Amyotrophic Lateral Sclerosis | 17 | 2025 | 504 | 4.800 |
Why?
|
| Hippocampus | 15 | 2025 | 270 | 4.290 |
Why?
|
| Epigenesis, Genetic | 14 | 2025 | 385 | 3.450 |
Why?
|
| Frontotemporal Dementia | 6 | 2025 | 149 | 2.500 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 9 | 2022 | 87 | 2.430 |
Why?
|
| Alzheimer Disease | 6 | 2025 | 721 | 2.410 |
Why?
|
| Motor Neurons | 8 | 2025 | 212 | 2.220 |
Why?
|
| Astrocytes | 10 | 2025 | 119 | 2.090 |
Why?
|
| Disks Large Homolog 4 Protein | 7 | 2025 | 21 | 2.020 |
Why?
|
| Dendrites | 6 | 2019 | 56 | 1.950 |
Why?
|
| Superoxide Dismutase-1 | 8 | 2025 | 143 | 1.870 |
Why?
|
| Neurogenesis | 5 | 2019 | 64 | 1.850 |
Why?
|
| Neurons | 18 | 2025 | 922 | 1.690 |
Why?
|
| Memory | 4 | 2025 | 120 | 1.590 |
Why?
|
| Mice, Transgenic | 13 | 2025 | 1277 | 1.490 |
Why?
|
| Neurodegenerative Diseases | 3 | 2025 | 143 | 1.480 |
Why?
|
| C9orf72 Protein | 3 | 2022 | 114 | 1.420 |
Why?
|
| Histones | 9 | 2025 | 481 | 1.420 |
Why?
|
| Animals | 55 | 2025 | 20663 | 1.380 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2018 | 337 | 1.290 |
Why?
|
| Neuronal Plasticity | 9 | 2025 | 150 | 1.230 |
Why?
|
| DNA Methylation | 4 | 2025 | 292 | 1.150 |
Why?
|
| Air Pollutants | 3 | 2025 | 93 | 1.140 |
Why?
|
| Air Pollution | 2 | 2025 | 35 | 1.090 |
Why?
|
| Membrane Proteins | 5 | 2016 | 895 | 1.070 |
Why?
|
| Rats | 19 | 2025 | 1981 | 1.060 |
Why?
|
| Mice | 30 | 2025 | 10843 | 1.040 |
Why?
|
| ras-GRF1 | 2 | 2019 | 3 | 0.960 |
Why?
|
| Synapses | 6 | 2013 | 184 | 0.910 |
Why?
|
| Axonal Transport | 1 | 2024 | 32 | 0.890 |
Why?
|
| Rats, Sprague-Dawley | 12 | 2025 | 619 | 0.870 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2024 | 94 | 0.850 |
Why?
|
| Huntington Disease | 1 | 2025 | 154 | 0.830 |
Why?
|
| Superoxide Dismutase | 5 | 2017 | 225 | 0.830 |
Why?
|
| Learning | 1 | 2025 | 182 | 0.800 |
Why?
|
| Disease Models, Animal | 12 | 2025 | 2186 | 0.760 |
Why?
|
| Parkinson Disease | 1 | 2024 | 131 | 0.760 |
Why?
|
| Receptors, Glycine | 6 | 2007 | 9 | 0.750 |
Why?
|
| Spinal Cord | 8 | 2025 | 204 | 0.740 |
Why?
|
| Connexins | 2 | 2021 | 9 | 0.740 |
Why?
|
| Osteoblasts | 6 | 2020 | 198 | 0.710 |
Why?
|
| Cells, Cultured | 15 | 2025 | 2157 | 0.710 |
Why?
|
| Mitochondria | 1 | 2024 | 371 | 0.700 |
Why?
|
| Mast Cells | 1 | 2021 | 39 | 0.690 |
Why?
|
| Histone Acetyltransferases | 1 | 2021 | 59 | 0.690 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 6 | 2020 | 142 | 0.670 |
Why?
|
| Transcriptional Activation | 4 | 2017 | 190 | 0.670 |
Why?
|
| Ion Channels | 1 | 2021 | 88 | 0.670 |
Why?
|
| Receptors, Purinergic P2X3 | 2 | 2018 | 5 | 0.660 |
Why?
|
| Ganglia, Spinal | 2 | 2018 | 30 | 0.660 |
Why?
|
| Transcription, Genetic | 7 | 2018 | 878 | 0.660 |
Why?
|
| Mutation | 10 | 2024 | 2612 | 0.650 |
Why?
|
| Superior Colliculi | 2 | 2010 | 12 | 0.640 |
Why?
|
| NADPH Oxidase 2 | 1 | 2019 | 35 | 0.620 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 3 | 2018 | 83 | 0.620 |
Why?
|
| Stress, Physiological | 1 | 2021 | 191 | 0.600 |
Why?
|
| Enzyme Inhibitors | 1 | 2021 | 373 | 0.600 |
Why?
|
| Gene Expression Regulation | 6 | 2021 | 1617 | 0.590 |
Why?
|
| Transcription Factors | 4 | 2021 | 1513 | 0.590 |
Why?
|
| Polycomb Repressive Complex 2 | 3 | 2020 | 16 | 0.590 |
Why?
|
| Signal Transduction | 7 | 2019 | 3035 | 0.580 |
Why?
|
| Cell Differentiation | 7 | 2019 | 1353 | 0.570 |
Why?
|
| Synaptic Transmission | 6 | 2015 | 149 | 0.570 |
Why?
|
| Freund's Adjuvant | 1 | 2018 | 14 | 0.570 |
Why?
|
| Hyperalgesia | 1 | 2018 | 15 | 0.570 |
Why?
|
| Epigenetic Repression | 1 | 2017 | 3 | 0.560 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2017 | 46 | 0.540 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2017 | 33 | 0.530 |
Why?
|
| LDL-Receptor Related Proteins | 1 | 2016 | 5 | 0.520 |
Why?
|
| Cognition | 2 | 2017 | 484 | 0.520 |
Why?
|
| Behavior, Animal | 2 | 2017 | 230 | 0.510 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2016 | 35 | 0.510 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2016 | 23 | 0.510 |
Why?
|
| Particulate Matter | 3 | 2025 | 64 | 0.500 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 2 | 2013 | 21 | 0.500 |
Why?
|
| Humans | 35 | 2025 | 63444 | 0.500 |
Why?
|
| Serine Endopeptidases | 1 | 2016 | 84 | 0.490 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2019 | 642 | 0.480 |
Why?
|
| Culture Media, Conditioned | 4 | 2025 | 51 | 0.480 |
Why?
|
| Cognitive Dysfunction | 1 | 2020 | 332 | 0.480 |
Why?
|
| Nerve Tissue Proteins | 3 | 2017 | 424 | 0.480 |
Why?
|
| Promoter Regions, Genetic | 6 | 2020 | 676 | 0.460 |
Why?
|
| Pyramidal Cells | 1 | 2014 | 26 | 0.430 |
Why?
|
| Polyphosphates | 2 | 2024 | 12 | 0.410 |
Why?
|
| Action Potentials | 2 | 2013 | 105 | 0.410 |
Why?
|
| Receptors, GABA-A | 2 | 2005 | 24 | 0.400 |
Why?
|
| TRPV Cation Channels | 1 | 2013 | 20 | 0.400 |
Why?
|
| Mice, Inbred C57BL | 10 | 2025 | 3396 | 0.400 |
Why?
|
| Patch-Clamp Techniques | 7 | 2015 | 130 | 0.390 |
Why?
|
| Sodium Channels | 1 | 2012 | 25 | 0.390 |
Why?
|
| Connexin 43 | 2 | 2023 | 13 | 0.390 |
Why?
|
| Glutamic Acid | 4 | 2022 | 99 | 0.380 |
Why?
|
| Fear | 2 | 2022 | 70 | 0.370 |
Why?
|
| Mammals | 2 | 2024 | 218 | 0.360 |
Why?
|
| Spinal Nerves | 2 | 2017 | 5 | 0.350 |
Why?
|
| Receptors, Kainic Acid | 1 | 2010 | 2 | 0.340 |
Why?
|
| Protein Subunits | 3 | 2014 | 166 | 0.340 |
Why?
|
| Transcriptome | 3 | 2020 | 387 | 0.340 |
Why?
|
| Pain | 1 | 2013 | 406 | 0.330 |
Why?
|
| Cell Death | 3 | 2024 | 284 | 0.320 |
Why?
|
| Brain Stem | 1 | 2008 | 28 | 0.300 |
Why?
|
| Genome-Wide Association Study | 2 | 2022 | 359 | 0.290 |
Why?
|
| Glycine | 2 | 2005 | 49 | 0.280 |
Why?
|
| Brain | 4 | 2022 | 1552 | 0.280 |
Why?
|
| Nerve Net | 1 | 2008 | 97 | 0.280 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 2 | 2020 | 15 | 0.280 |
Why?
|
| Carrier Proteins | 2 | 2016 | 707 | 0.260 |
Why?
|
| Gene Silencing | 3 | 2020 | 400 | 0.240 |
Why?
|
| KCNQ2 Potassium Channel | 1 | 2025 | 3 | 0.240 |
Why?
|
| Receptors, GABA | 1 | 2025 | 12 | 0.240 |
Why?
|
| Up-Regulation | 4 | 2023 | 374 | 0.240 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2017 | 86 | 0.240 |
Why?
|
| Olfactory Bulb | 1 | 2025 | 19 | 0.240 |
Why?
|
| RNA Interference | 3 | 2020 | 618 | 0.230 |
Why?
|
| Microtubules | 2 | 2003 | 209 | 0.230 |
Why?
|
| Animals, Newborn | 4 | 2017 | 239 | 0.230 |
Why?
|
| Neuroprotective Agents | 1 | 2025 | 75 | 0.230 |
Why?
|
| Male | 11 | 2025 | 29891 | 0.220 |
Why?
|
| Gene Expression | 2 | 2020 | 840 | 0.210 |
Why?
|
| Membrane Potentials | 3 | 2010 | 141 | 0.200 |
Why?
|
| Protein Binding | 3 | 2017 | 1603 | 0.190 |
Why?
|
| Chromatin | 3 | 2022 | 608 | 0.190 |
Why?
|
| Basolateral Nuclear Complex | 1 | 2022 | 7 | 0.190 |
Why?
|
| MicroRNAs | 2 | 2020 | 687 | 0.190 |
Why?
|
| Neurotransmitter Agents | 1 | 2022 | 42 | 0.180 |
Why?
|
| Cell Line | 3 | 2021 | 2040 | 0.180 |
Why?
|
| Memory, Short-Term | 1 | 2022 | 60 | 0.180 |
Why?
|
| Cytoskeleton | 1 | 2002 | 139 | 0.180 |
Why?
|
| Cell Degranulation | 1 | 2021 | 20 | 0.180 |
Why?
|
| Acetylation | 2 | 2020 | 120 | 0.170 |
Why?
|
| Brain Injuries | 1 | 2023 | 140 | 0.170 |
Why?
|
| Primary Cell Culture | 3 | 2017 | 78 | 0.170 |
Why?
|
| Interneurons | 1 | 2000 | 22 | 0.170 |
Why?
|
| Calcium | 3 | 2013 | 575 | 0.170 |
Why?
|
| Oligonucleotides, Antisense | 2 | 2016 | 144 | 0.170 |
Why?
|
| Dentate Gyrus | 2 | 2016 | 13 | 0.160 |
Why?
|
| Dipeptides | 1 | 2020 | 67 | 0.160 |
Why?
|
| Down-Regulation | 1 | 2020 | 319 | 0.160 |
Why?
|
| Superoxides | 1 | 2019 | 71 | 0.160 |
Why?
|
| Cell Movement | 2 | 2019 | 453 | 0.150 |
Why?
|
| Phenotype | 3 | 2017 | 1207 | 0.150 |
Why?
|
| Osteogenesis | 2 | 2017 | 143 | 0.150 |
Why?
|
| Neural Stem Cells | 1 | 2019 | 48 | 0.150 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2018 | 6 | 0.150 |
Why?
|
| Cell Lineage | 2 | 2017 | 270 | 0.150 |
Why?
|
| Histone Demethylases | 1 | 2018 | 10 | 0.150 |
Why?
|
| Circulating MicroRNA | 1 | 2017 | 5 | 0.140 |
Why?
|
| DNA Damage | 1 | 2020 | 287 | 0.140 |
Why?
|
| Histone Code | 1 | 2017 | 26 | 0.140 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2017 | 14 | 0.140 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2018 | 41 | 0.140 |
Why?
|
| Transfection | 2 | 2017 | 694 | 0.140 |
Why?
|
| Wharton Jelly | 1 | 2017 | 3 | 0.130 |
Why?
|
| Ethanol | 1 | 2000 | 321 | 0.130 |
Why?
|
| Zinc Fingers | 1 | 2017 | 103 | 0.130 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2017 | 86 | 0.130 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2016 | 489 | 0.130 |
Why?
|
| Dendritic Spines | 1 | 2016 | 11 | 0.130 |
Why?
|
| Cytokines | 1 | 2021 | 935 | 0.130 |
Why?
|
| Glutathione Transferase | 1 | 2016 | 41 | 0.130 |
Why?
|
| Genes, Dominant | 1 | 2016 | 57 | 0.130 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 2008 | 75 | 0.130 |
Why?
|
| Gestational Age | 1 | 2017 | 189 | 0.130 |
Why?
|
| Ozone | 1 | 2016 | 16 | 0.130 |
Why?
|
| PC12 Cells | 2 | 2013 | 27 | 0.130 |
Why?
|
| Transforming Growth Factor beta | 1 | 2017 | 172 | 0.130 |
Why?
|
| Apolipoprotein E4 | 1 | 2016 | 46 | 0.120 |
Why?
|
| Procollagen-Proline Dioxygenase | 1 | 2016 | 6 | 0.120 |
Why?
|
| Dendritic Cells | 1 | 2019 | 525 | 0.120 |
Why?
|
| Protein Disulfide-Isomerases | 1 | 2016 | 15 | 0.120 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 130 | 0.120 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 187 | 0.120 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2015 | 17 | 0.120 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2017 | 263 | 0.120 |
Why?
|
| Muscle, Skeletal | 2 | 2018 | 741 | 0.120 |
Why?
|
| Stem Cells | 1 | 2017 | 259 | 0.120 |
Why?
|
| Long-Term Potentiation | 1 | 2015 | 43 | 0.120 |
Why?
|
| Ribosomal Proteins | 1 | 2015 | 43 | 0.120 |
Why?
|
| Reactive Oxygen Species | 1 | 2016 | 224 | 0.110 |
Why?
|
| Receptors, AMPA | 2 | 2015 | 42 | 0.110 |
Why?
|
| Female | 10 | 2020 | 32878 | 0.110 |
Why?
|
| Strychnine | 2 | 2007 | 4 | 0.110 |
Why?
|
| Autoantibodies | 1 | 2015 | 182 | 0.110 |
Why?
|
| Motor Activity | 1 | 2017 | 346 | 0.110 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2015 | 165 | 0.100 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 202 | 0.100 |
Why?
|
| Myosin Type V | 1 | 2013 | 12 | 0.100 |
Why?
|
| Trehalose | 1 | 2013 | 8 | 0.100 |
Why?
|
| Peptides | 1 | 2017 | 574 | 0.100 |
Why?
|
| Voltage-Gated Sodium Channel Blockers | 1 | 2013 | 4 | 0.100 |
Why?
|
| Neural Inhibition | 2 | 2004 | 29 | 0.100 |
Why?
|
| Visual Cortex | 1 | 2013 | 26 | 0.100 |
Why?
|
| Myosin Heavy Chains | 1 | 2013 | 44 | 0.100 |
Why?
|
| Sodium | 1 | 2013 | 61 | 0.100 |
Why?
|
| DNA-Binding Proteins | 2 | 2015 | 1186 | 0.100 |
Why?
|
| Electric Stimulation | 2 | 2013 | 139 | 0.100 |
Why?
|
| In Vitro Techniques | 2 | 2013 | 490 | 0.090 |
Why?
|
| Calcium Signaling | 1 | 2013 | 157 | 0.090 |
Why?
|
| Pregnancy | 3 | 2020 | 2334 | 0.090 |
Why?
|
| Autophagy | 1 | 2013 | 225 | 0.090 |
Why?
|
| Thy-1 Antigens | 2 | 2023 | 21 | 0.090 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 770 | 0.080 |
Why?
|
| Gliosis | 2 | 2023 | 28 | 0.080 |
Why?
|
| Aging | 1 | 2016 | 745 | 0.080 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 921 | 0.080 |
Why?
|
| Synaptic Potentials | 1 | 2010 | 6 | 0.080 |
Why?
|
| Nuclear Matrix | 1 | 2010 | 28 | 0.080 |
Why?
|
| Calcitriol | 1 | 2010 | 25 | 0.080 |
Why?
|
| Receptors, Calcitriol | 1 | 2010 | 34 | 0.080 |
Why?
|
| Genetic Therapy | 1 | 2016 | 791 | 0.080 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2008 | 19 | 0.070 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2008 | 52 | 0.070 |
Why?
|
| Disease Progression | 1 | 2013 | 1172 | 0.070 |
Why?
|
| Mexico | 2 | 2020 | 39 | 0.070 |
Why?
|
| Cities | 2 | 2020 | 30 | 0.070 |
Why?
|
| Neural Pathways | 1 | 2008 | 99 | 0.070 |
Why?
|
| Functional Laterality | 1 | 2008 | 138 | 0.070 |
Why?
|
| Fibrosis | 2 | 2018 | 160 | 0.070 |
Why?
|
| Glutathione | 1 | 2007 | 54 | 0.070 |
Why?
|
| Ascorbic Acid | 1 | 2007 | 50 | 0.070 |
Why?
|
| Glycine Agents | 2 | 2004 | 5 | 0.060 |
Why?
|
| Animals, Genetically Modified | 2 | 2017 | 290 | 0.060 |
Why?
|
| Endothelial Cells | 1 | 2007 | 187 | 0.060 |
Why?
|
| Oxidative Stress | 1 | 2007 | 298 | 0.060 |
Why?
|
| Antioxidants | 1 | 2007 | 252 | 0.060 |
Why?
|
| Fetus | 1 | 2005 | 99 | 0.060 |
Why?
|
| Nerve Degeneration | 1 | 2025 | 72 | 0.060 |
Why?
|
| Presynaptic Terminals | 1 | 2004 | 37 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2007 | 863 | 0.050 |
Why?
|
| Embryo, Mammalian | 2 | 2016 | 157 | 0.050 |
Why?
|
| Serine | 2 | 2022 | 91 | 0.050 |
Why?
|
| Integrin alpha5 | 1 | 2023 | 7 | 0.050 |
Why?
|
| Integrin beta3 | 1 | 2023 | 6 | 0.050 |
Why?
|
| Phosphorylation | 2 | 2023 | 936 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2023 | 171 | 0.050 |
Why?
|
| Colchicine | 1 | 2002 | 28 | 0.050 |
Why?
|
| Ion Transport | 1 | 2002 | 21 | 0.050 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2002 | 37 | 0.050 |
Why?
|
| Biomarkers | 2 | 2017 | 1408 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2023 | 207 | 0.050 |
Why?
|
| Oxidation-Reduction | 2 | 2016 | 326 | 0.040 |
Why?
|
| Adenosine Triphosphate | 1 | 2023 | 293 | 0.040 |
Why?
|
| Binding Sites | 3 | 2012 | 905 | 0.040 |
Why?
|
| Picrotoxin | 1 | 2000 | 5 | 0.040 |
Why?
|
| 3' Untranslated Regions | 1 | 2020 | 94 | 0.040 |
Why?
|
| Chile | 1 | 2020 | 14 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 207 | 0.040 |
Why?
|
| Zinc | 1 | 2000 | 92 | 0.040 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2020 | 146 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 542 | 0.040 |
Why?
|
| Blotting, Western | 1 | 2020 | 612 | 0.040 |
Why?
|
| Adult Stem Cells | 1 | 2019 | 28 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 1 | 2020 | 401 | 0.040 |
Why?
|
| Mice, Inbred mdx | 1 | 2018 | 15 | 0.040 |
Why?
|
| Cell Survival | 2 | 2013 | 575 | 0.040 |
Why?
|
| 3T3 Cells | 1 | 2018 | 110 | 0.040 |
Why?
|
| Child | 2 | 2020 | 4526 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2020 | 622 | 0.040 |
Why?
|
| Neuromuscular Junction | 1 | 2018 | 77 | 0.040 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2017 | 9 | 0.030 |
Why?
|
| Locomotion | 1 | 2018 | 116 | 0.030 |
Why?
|
| Oncogene Proteins | 1 | 1997 | 33 | 0.030 |
Why?
|
| Young Adult | 2 | 2020 | 4694 | 0.030 |
Why?
|
| Sp7 Transcription Factor | 1 | 2017 | 4 | 0.030 |
Why?
|
| Rotarod Performance Test | 1 | 2017 | 3 | 0.030 |
Why?
|
| Atrophy | 1 | 2017 | 83 | 0.030 |
Why?
|
| Methylation | 1 | 2017 | 129 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2017 | 185 | 0.030 |
Why?
|
| Antibodies, Neutralizing | 1 | 2018 | 209 | 0.030 |
Why?
|
| Wechsler Scales | 1 | 2016 | 16 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p57 | 1 | 2016 | 7 | 0.030 |
Why?
|
| Adipogenesis | 1 | 2017 | 79 | 0.030 |
Why?
|
| Wound Healing | 1 | 2017 | 189 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2017 | 139 | 0.030 |
Why?
|
| Neurites | 1 | 2016 | 23 | 0.030 |
Why?
|
| Inflammation | 1 | 2023 | 1147 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2016 | 44 | 0.030 |
Why?
|
| Electromyography | 1 | 2016 | 96 | 0.030 |
Why?
|
| CA3 Region, Hippocampal | 1 | 2015 | 5 | 0.030 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2015 | 10 | 0.030 |
Why?
|
| Embryo, Nonmammalian | 1 | 2016 | 178 | 0.030 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2015 | 46 | 0.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2015 | 43 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 1997 | 346 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 615 | 0.030 |
Why?
|
| Antigens, Surface | 1 | 2015 | 197 | 0.030 |
Why?
|
| Environmental Exposure | 1 | 2016 | 218 | 0.030 |
Why?
|
| Recombinant Proteins | 2 | 2012 | 702 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2016 | 484 | 0.030 |
Why?
|
| Excitatory Amino Acid Agents | 1 | 2013 | 5 | 0.030 |
Why?
|
| Guanylate Kinases | 1 | 2013 | 8 | 0.030 |
Why?
|
| Cytoprotection | 1 | 2013 | 18 | 0.030 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2013 | 17 | 0.030 |
Why?
|
| Synaptosomes | 1 | 2013 | 16 | 0.030 |
Why?
|
| Biophysics | 1 | 2013 | 42 | 0.030 |
Why?
|
| Electroporation | 1 | 2013 | 35 | 0.030 |
Why?
|
| Protein Structure, Quaternary | 1 | 2013 | 100 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2013 | 127 | 0.020 |
Why?
|
| Neuroglia | 1 | 2013 | 79 | 0.020 |
Why?
|
| Zebrafish | 1 | 2016 | 347 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2013 | 128 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2013 | 302 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2016 | 866 | 0.020 |
Why?
|
| Longevity | 1 | 2013 | 113 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2013 | 367 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2012 | 248 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2016 | 2109 | 0.020 |
Why?
|
| Mediator Complex Subunit 1 | 1 | 2010 | 7 | 0.020 |
Why?
|
| Adult | 2 | 2017 | 16825 | 0.020 |
Why?
|
| Time Factors | 1 | 2017 | 3769 | 0.020 |
Why?
|
| Ligands | 1 | 2010 | 416 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2010 | 238 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 673 | 0.020 |
Why?
|
| Oxidants | 1 | 2007 | 18 | 0.020 |
Why?
|
| Respiratory Burst | 1 | 2007 | 21 | 0.020 |
Why?
|
| 6-Cyano-7-nitroquinoxaline-2,3-dione | 1 | 2007 | 5 | 0.020 |
Why?
|
| Bicuculline | 1 | 2007 | 6 | 0.020 |
Why?
|
| Receptor, trkB | 1 | 2007 | 7 | 0.020 |
Why?
|
| Hydrogen Peroxide | 1 | 2007 | 78 | 0.020 |
Why?
|
| Oxidoreductases | 1 | 2007 | 64 | 0.020 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2007 | 35 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2010 | 1469 | 0.020 |
Why?
|
| Adolescent | 1 | 2016 | 6245 | 0.010 |
Why?
|
| DNA | 1 | 2010 | 837 | 0.010 |
Why?
|
| Receptor Aggregation | 1 | 2004 | 5 | 0.010 |
Why?
|
| Homeostasis | 1 | 2007 | 368 | 0.010 |
Why?
|
| Aged | 1 | 2017 | 14446 | 0.010 |
Why?
|
| Interferon Regulatory Factor-2 | 1 | 1997 | 5 | 0.010 |
Why?
|
| Casein Kinase II | 1 | 1997 | 16 | 0.010 |
Why?
|
| COS Cells | 1 | 1997 | 175 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 1997 | 102 | 0.010 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 1997 | 93 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 1997 | 220 | 0.010 |
Why?
|